Review: Pathophysiology and treatment of bacterial meningitis
Open accessThe DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Bacterial meningitis is a medical emergency requiring immediate diagnosis and immediate treatment. Streptococcus pneumoniae and Neisseria meningitidis are the most common and most aggressive pathogens of meningitis. Emerging antibiotic resistance is an upcoming challenge. Clinical and experimental studies have established a more detailed understanding of the mechanisms resulting in brain damage, sequelae and neuropsychological deficits. We summarize the current pathophysiological concept of acute bacterial meningitis and present current treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“For instance, a high WBC count (≥ 500 cells/μl) with a large proportion of neutrophils (>80%) is usually observed in bacterial meningitis. Furthermore, in bacterial meningitis, the CSF glucose level typically does not exceed (300 mg/dL), but a decreased glucose CSF/blood ratio (< 0.4), and an elevated protein level (1 g/l) are indications of bacterial meningitis [2].”
From Viral meningitis: an overview (2021) · cites this paper as [2]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Gram staining and bacterial culture are the key diagnostic tools for identifying bacterial infections [2], and viral meningitis is suspected when Gram staining and culture of CSF are negative.”
From Viral meningitis: an overview (2021) · cites this paper as [2]
In the citing paper
“In the recent decade, S. pneumoniae has been considered as the main causative agent of bacterial meningitis in children aged <10 years, in elder population, and in immunocompromised patients in the United States and European countries [16].”
From Frequency of etiological agents of acute bacterial meningitis using culture and polymerase chain reaction assay (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308 · cited 1×
“The data for treatment durations are very limited and mostly based on expert opinion [Tunkel et al. 2004].”
MethodWhitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Cell Activation and Apoptosis by Bacterial Lipoproteins Through Toll-like Receptor-2
Aliprantis, A. O., Yang, R.-B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., Klimpel, G. R., Godowski, P., & Zychlinsky, A. (1999) · Science · doi:10.1126/science.285.5428.736 · Cited by 1,474
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Dexamethasone in Adults with Bacterial Meningitis
de Gans, J., & van de Beek, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021334 · Cited by 1,205
Lehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978 · cited 1×
“WHO estimates at least 500 000 newly symptomatic infections per year worldwide, leading to at least 50 000 deaths [Stephens et al. 2007].”
BackgroundIncreasing Prevalence of Multidrug-Resistant Streptococcus pneumoniae in the United States
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Lexau, C., Reingold, A., Lefkowitz, L., Cieslak, P. R., Cetron, M., Zell, E. R., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200012283432603 · Cited by 888 · cited 2×
“…in unraveling the molecular basis of bacterial meningitis, developing new treatments and meeting new upcoming challenges such as increasing resistance of pathogens to currently used antibiotics; for example, pneumococci up to 35% [Richter et al. 2002; Doern et al. 2001; Whitney et al. 2000].”
BackgroundCommunity-Acquired Bacterial Meningitis in Adults
van de Beek, D., de Gans, J., Tunkel, A. R., & Wijdicks, E. F. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052116 · Cited by 880
Research works printed but not linked: 2
- 10.1097/00005072-199903000-00006 · DOI · Paper page
- Simberkoff, M.S., 1980, J Lab Clin Med, 95, 362
Cited by
Neisseria gonorrhoeae host adaptation and pathogenesis
Quillin, S. J., & Seifert, H. S. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.169 · Cited by 372
IL-1 receptor 2 (IL-1R2) and its role in immune regulation
Peters, V. A., Joesting, J. J., & Freund, G. G. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2012.11.006 · Cited by 264
Kohil, A., Jemmieh, S., Smatti, M. K., & Yassine, H. M. (2021) · Archives of Virology · doi:10.1007/s00705-020-04891-1 · Cited by 164
Zainel, A., Mitchell, H., & Sadarangani, M. (2021) · Microorganisms · doi:10.3390/microorganisms9030535 · Cited by 202
Multiple Sclerosis: Molecular Mechanisms and Therapeutic Opportunities
Miljković, D., & Spasojević, I. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5068 · Cited by 134
Metadata
- Authors
- Hoffman, O., & Weber, J. R.
- Affiliations
- Klinikum Klagenfurt (AT)
- Charité – Universitätsmedizin Berlin (DE)
- Venue
- Therapeutic Advances in Neurological Disorders
- Publisher
- SAGE Publications
- Published
- 2009-06-02
- Volume
- 2
- Issue
- 6
- Pages
- 401-412
- ISSN
- 1756-2856 (ISSN-L)
- 1756-2864
- PMC
- PMC3002609
- OpenAlex
- W1532860571
- Cited by
- 179
- References
- 105
- Citations by year
- 2026: 5 · 2025: 13 · 2024: 16 · 2023: 24 · 2022: 16 · 2021: 15 · 2020: 19 · 2019: 14 · 2018: 10 · 2017: 11 · 2016: 3 · 2015: 15 · 2014: 4 · 2013: 7 · 2012: 5
- FWCI
- 2.25
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Therapeutic Advances in Neurological Disorders (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- bacterial meningitis, pathophysiology, Streptococcus pneumoniae, Neisseria meningitidis, antibiotic resistance, brain damage, neuropsychological deficits, meningitis treatment, meningitis sequelae
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Review: Pathophysiology and treatment of bacterial meningitis. https://app.cochat.ai/papers/10.1177/1756285609337975
- The paper
- Hoffman, O., & Weber, J. R. (2009). Review: Pathophysiology and treatment of bacterial meningitis. Therapeutic Advances in Neurological Disorders. https://doi.org/10.1177/1756285609337975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.